Puerarin Inhibits Hepatocellular Carcinoma Invasion and Metastasis Through miR-21-mediated PTEN/AKT Signaling to Suppress the Epithelial-Mesenchymal Transition

Brazilian Journal of Medical and Biological Research- Brazil

doi 10.1590/1414-431x20198882

Full Text

Abstract

Available in

Date

Authors

Publisher

FapUNIFESP (SciELO)

Related search

JARID2 Promotes Invasion and Metastasis of Hepatocellular Carcinoma by Facilitating Epithelial-Mesenchymal Transition Through PTEN/AKT Signaling

Oncotarget
Oncology
2016English

STYK1 Promotes Epithelial-Mesenchymal Transition and Tumor Metastasis in Human Hepatocellular Carcinoma Through MEK/ERK and PI3K/AKT Signaling

Scientific Reports
Multidisciplinary
2016English

Metadherin Promotes Hepatocellular Carcinoma Metastasis Through Induction of Epithelial-Mesenchymal Transition

Clinical Cancer Research
Cancer ResearchOncology
2011English

FAM 134B Induces Tumorigenesis and Epithelial‐to‐mesenchymal Transition via Akt Signaling in Hepatocellular Carcinoma

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2018English

Cinobufacini Inhibits Epithelial-Mesenchymal Transition of Human Hepatocellular Carcinoma Cells Through C-Met/Erk Signaling Pathway

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2018English

Blocking PI3K/Akt Signaling Attenuates Metastasis of Nasopharyngeal Carcinoma Cells Through Induction of Mesenchymal-Epithelial Reverting Transition

Oncology Reports
MedicineCancer ResearchOncology
2014English

LncRNA HULC Enhances Epithelial-Mesenchymal Transition to Promote Tumorigenesis and Metastasis of Hepatocellular Carcinoma via the miR-200a-3p/ZEB1 Signaling Pathway

Oncotarget
Oncology
2016English

miR-573 Inhibits Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition

Oncotarget
Oncology
2015English

CRISPR-Cas9 Mediated CD133 Knockout Inhibits Colon Cancer Invasion Through Reduced Epithelial-Mesenchymal Transition

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy